首页> 外文期刊>AACE International Transactions >Project Execution Risk Management in the Biopharmaceutical Industry - A Life Cycle Approach
【24h】

Project Execution Risk Management in the Biopharmaceutical Industry - A Life Cycle Approach

机译:生物制药行业中的项目执行风险管理-生命周期方法

获取原文
获取原文并翻译 | 示例
           

摘要

The biopharmaceutical industry has many challenges including technical, organizational and societal. This fast paced industry is continuously buffeted by new product developments, technological changes, as well as evolving patient requirements and aggressive industry competition. To help address these many challenges an approach was developed using off-the- shelf tools (Excel, Primavera and Pertmaster) to achieve a standard and straightforward methodology to insure consistent, reliable risk management and establish a basis for continuous management of risks throughout the project life. Benefits include a clear and easy to use risk register with responsible risk owners and risk ranking for focus and mitigation; simulation of project cost and schedule impact via project risk models to facilitate decision-making; promotion of active participation from a diverse user group, and the opportunity to focus the combined knowledge and experience of the team to enhance project performance. This approach ultimately transformed risk management from a negative paradigm into a positive, synergistic, team building, group educating, and solution-generating experience.
机译:生物制药行业面临许多挑战,包括技术,组织和社会。快速发展的行业不断受到新产品开发,技术变化以及不断变化的患者需求和激进的行业竞争的冲击。为了帮助解决这些挑战,开发了一种使用现成的工具(Excel,Primavera和Pertmaster)的方法,以实现一种标准而直接的方法,以确保一致,可靠的风险管理,并为整个项目的持续风险管理奠定基础生活。收益包括与负责任的风险所有者建立清晰易用的风险登记簿,以及针对重点和缓解风险的风险等级;通过项目风险模型模拟项目成本和进度影响,以促进决策;促进多元化用户群体的积极参与,并有机会集中团队的知识和经验,以提高项目绩效。这种方法最终将风险管理从否定范式转变为积极,协同,团队建设,小组教育和解决方案生成的经验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号